![Loss of Chromatin-Remodeling Proteins and/or CDKN2A Associates With Metastasis of Pancreatic Neuroendocrine Tumors and Reduced Patient Survival Times - Gastroenterology Loss of Chromatin-Remodeling Proteins and/or CDKN2A Associates With Metastasis of Pancreatic Neuroendocrine Tumors and Reduced Patient Survival Times - Gastroenterology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2d00dfb7-1170-4c78-9956-1d1f22cd8064/gr1.jpg)
Loss of Chromatin-Remodeling Proteins and/or CDKN2A Associates With Metastasis of Pancreatic Neuroendocrine Tumors and Reduced Patient Survival Times - Gastroenterology
![SMAD4 loss is associated with response to neoadjuvant chemotherapy plus hydroxychloroquine in patients with pancreatic adenocarcinoma - Fei - 2021 - Clinical and Translational Science - Wiley Online Library SMAD4 loss is associated with response to neoadjuvant chemotherapy plus hydroxychloroquine in patients with pancreatic adenocarcinoma - Fei - 2021 - Clinical and Translational Science - Wiley Online Library](https://ascpt.onlinelibrary.wiley.com/cms/asset/c1f2d327-3674-476e-a18a-280064926a0b/cts13029-fig-0001-m.jpg)
SMAD4 loss is associated with response to neoadjuvant chemotherapy plus hydroxychloroquine in patients with pancreatic adenocarcinoma - Fei - 2021 - Clinical and Translational Science - Wiley Online Library
![SMAD4 loss is associated with response to neoadjuvant chemotherapy plus hydroxychloroquine in patients with pancreatic adenocarcinoma - Fei - - Clinical and Translational Science - Wiley Online Library SMAD4 loss is associated with response to neoadjuvant chemotherapy plus hydroxychloroquine in patients with pancreatic adenocarcinoma - Fei - - Clinical and Translational Science - Wiley Online Library](https://ascpt.onlinelibrary.wiley.com/cms/asset/98ba1cac-242b-413e-bf49-1d5e9fc5e428/cts.v14.3.cover.jpg)